EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition

Valentina Giudice iD, Bianca Serio iD, Santa Errichiello iD, Idalucia Ferrara iD, Alessandra Galdiero iD, Angela Bertolini iD, Roberta Visconti iD, Danilo De Novellis iD, Roberto Guariglia iD, Serena Luponio iD, Denise Morini iD, Anna Maria Della Corte iD und 5 weitere

European Journal of Haematology · 2023

DOI: 10.1111/ejh.14069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Valentina Giudice und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural Program of the Department of Medicine, Surgery and Dentistry, University of Salerno.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Splicing modifications, genomic instability, and hypomethylation are central mechanisms promoting myelodysplasia and acute myeloid leukemia (AML). In this real‐life retrospective study, to elucidate pathophysiology of clonal hemopoiesis in hematological malignancies, we investigated clinical significance of mutations in leukemia‐related genes of known pathogenetic significance and of variants of uncertain clinical significance (VUS) in a cohort of patients with MDS and AML.

Methods

A total of 59 consecutive subjects diagnosed with MDS, 48 with AML, and 17 with clonal cytopenia with unknown significance were screened for somatic mutations in AML‐related genes by next‐generation sequencing.

Results

We showed that TET2 , SETBP1 , ASXL1 , EZH2 , RUNX1 , SRSF2 , DNMT3A , and IDH1/2 were commonly mutated. MDS patients also showed a high genetic complexity, especially for SETBP1 . Moreover, the presence of SETBP1 wild‐type or two or more simultaneous VUS variants identified a subgroup of AML and MDS patients with better outcome, while the presence of single SETBP1 VUS variant was related to a worse prognosis, regardless TET2 mutational status.

Conclusions

In conclusions, we linked both pathogenic and VUS variants in AML‐related genes to clonal hematopoiesis; therefore, we proposed to consider those variants as prognostic markers in leukemia and myelodysplasia. However, further studies in larger prospective cohorts are required to validate our results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesLeukemia, Myeloid, AcuteHumansRetrospective StudiesProspective StudiesClinical RelevanceMutationDisease SusceptibilityPrognosis

Stichwörter der Autor:innen

acute myeloid leukemiaclonal hematopoiesismyelodysplastic syndromespathogenic mutationsvariants of uncertain significance

Autor:innen und Institutionen

  • Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
  • Department of Medicine, Surgery, and Dentistry, University of Salerno, Baronissi, Italy.
  • Department of Molecular Medicine and Medical Biotechnology, CEINGE-Biotecnologie Avanzate, University of Naples "Federico II", Naples, Italy.

ORCID-Profile: Valentina Giudice, Bianca Serio, Santa Errichiello, Idalucia Ferrara, Alessandra Galdiero, Angela Bertolini, Roberta Visconti, Danilo De Novellis, Roberto Guariglia, Serena Luponio, Denise Morini, Anna Maria Della Corte, Anna Maria Sessa, Francesco Verdesca, Maddalena Langella, Barbara Izzo, Carmine Selleri

Förderung

  • Intramural Program of the Department of Medicine, Surgery and Dentistry, University of Salerno

Zitieren

APA

Giudice, V., Serio, B., Errichiello, S., Ferrara, I., Galdiero, A., Bertolini, A., Visconti, R., De Novellis, D., Guariglia, R., Luponio, S., Morini, D., Della Corte, A. M., Sessa, A. M., Verdesca, F., Langella, M., Izzo, B., & Selleri, C. (2023). Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. European Journal of Haematology. https://doi.org/10.1111/ejh.14069

Vancouver

Giudice V, Serio B, Errichiello S, Ferrara I, Galdiero A, Bertolini A, et al. Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. European Journal of Haematology. 2023. doi:10.1111/ejh.14069

BibTeX
@article{Giudice2023,
  author = {Giudice, Valentina and Serio, Bianca and Errichiello, Santa and Ferrara, Idalucia and Galdiero, Alessandra and Bertolini, Angela and Visconti, Roberta and De Novellis, Danilo and Guariglia, Roberto and Luponio, Serena and Morini, Denise and Della Corte, Anna Maria and Sessa, Anna Maria and Verdesca, Francesco and Langella, Maddalena and Izzo, Barbara and Selleri, Carmine},
  title = {Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition},
  journal = {European Journal of Haematology},
  year = {2023},
  doi = {10.1111/ejh.14069}
}
Kostenlos starten →